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quality has been described in cases where skin changes 
occurred because of an imbalance of extracellular 
factors.2,3 Thus, a clear distinction should be made 
in future studies using lipofilling for skin rejuvena-
tion purposes of “ordinary” aged skin or pathologic 
processes of the skin (e.g., scars, fibrotic diseases, or 
wound healing). Thus far, the only proven effective 
application for lipofilling is the restoration of vol-
ume loss.4 Moreover, the volumizing effect of lipofill-
ing results in reduction of dermal wrinkles as well by 
increasing subcutaneous volume.
As a second point, Valente and Zanella suggested 
that we overstate our results with regard to the safety 
of facial lipofilling in the Conclusions section of our 
systematic review. A systematic review that is conducted 
according to validated guidelines can provide collated 
information of the specific question one might want 
answered. As a result of following these validated guide-
lines, self-bias and our own opinion are reduced to a 
minimum. The question that was asked by the authors, 
whether facial lipofilling is a safe procedure, can con-
sequently not be answered by a single study of a single 
center that in their case demonstrated an infection 
rate of 4.8 percent and an overall complication rate of 
13.6 percent.5 Moreover, all other studies included in 
our systematic review did not mention any complica-
tion. This might be because of selectively not reporting 
nonsignificant minor complications. Nevertheless, the 
safety of facial lipofilling is an interesting and clinically 
relevant issue.
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Reply: The Effects of Facial Lipografting on  
Skin Quality: A Systematic Review
Sir: 
We would like to thank Valente and Zanella for 
their letter in response to our systematic review.1 The 
first remark by Valente and Zanella contradicts our 
main conclusion: facial lipofilling or any component 
of adipose tissue (e.g., stromal vascular fraction or 
adipose-derived stromal cells) does not detectably, 
measurably rejuvenate aged skin.1 However, scientific 
evidence of well-executed randomized clinical trials 
with validated measurement tools is lacking, and the 
only published well-designed randomized clinical trial 
shows no effect of facial lipofilling on skin elasticity. 
Our hypothesis is that ordinary aging of the skin is a 
normal physiologic process in which certain compo-
nents of the extracellular matrix (e.g., elastin) gradu-
ally disappear because of wear and tear and ultraviolet 
exposure causing deformations. In other aspects, such 
as epidermal regeneration, perfusion, and neurosen-
sation, no remarkable changes occur because of aging. 
Thus, adipose-derived stromal cells in adipose tissue 
have little to repair. Moreover, de novo generation 
of dermal elastin is often considered absent or inef-
ficient; however, this would not lead to tightening of 
the expanded aged tissue. In this way, aging-related 
skin changes are not considered damaged tissue and 
do not result in clinically identifiable changes of the 
skin as a result of facial lipofilling. In comparison, 
pathologic processes (e.g., dermal fibrosis or chronic 
wounds) go along with an imbalance of extracellular 
factors, resulting in inflammation, excessive extracel-
lular matrix deposition and crosslinking, or a lack of 
angiogenesis. Lipografting reeducates the damaged 
tissue by the stromal vascular fraction of adipose tis-
sue. Although no significant improvements have been 
described as a result of lipofilling applied to the “ordi-
nary” aging skin, significant improvement of the skin 
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Reply: Removal of Nasal Silicone Implant and 
the Impact of Subsequent Capsulectomy
Sir:
We appreciate the interest in our article1 shown 
by Drs. Pu and Han and thank them for raising some 
good questions. All operations were performed at a sin-
gle center, but the photographic and statistical analyses 
were performed in cooperation with the Department 
of Plastic and Reconstructive Surgery and the Depart-
ment of Biomedical Statistics at Yonsei University Col-
lege of Medicine (Seoul, Republic of Korea). Statistical 
analysis was performed by analysis of variance and 
three groups were not comparable, too much bias was 
not taken into consideration, and some mixed factors 
that should be balanced out before analysis potentially 
influence the credibility of conclusions. For instance, 
group 3, which preoperatively had a more severe nasal 
contraction than the other two groups, achieved the 
greatest improvement after a series of operations, 
including capsulectomy, silicone implant, and tip graft 
removal, but attributing these different initial levels of 
improvement to capsulectomy was clearly invalid.
Furthermore, the explicit definition for remark-
able contracted nasal appearance was not given, which 
meant that the criteria for choosing capsulectomy were 
subjective. It was also not reasonable or reliable to set 
those criteria as capsulectomy indications.
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Removal of Nasal Silicone Implant and the 
Impact of Subsequent Capsulectomy
Sir:
In the article by Kook et al.,1 a concomitant periim-plant capsulectomy is verified to be required in post-
rhinoplasty silicone implant extraction. Preremoval/
postremoval nasal bridge length index and nasolabial 
angle were measured as clinical endpoints for evalu-
ating the effect of subsequent capsulectomy in pre-
venting and correcting the deformity. However, some 
problems related to reliability and credibility still need 
to be clarified in this study.
First, this study is a retrospective analysis of a small 
sample in a single center. A previous study indicated that 
denatured changes are related not only to silicone itself 
but also to each person’s immunity and general health 
condition and thus his or her propensity for foreign 
body reaction and inflammatory changes.2 Therefore, 
some common factors such as age, sex, and various rea-
sons for revision surgery should be included in the mul-
tifactor analysis. In addition, baseline conditions of the 
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